Castle Biosciences Inc. (CSTL) Tops Q2 EPS by 70c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- Wall St rises as oil falls heading into US midterm elections
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Why has the market become so unforgiving of AI earnings?
- EchoStar rises on report SpaceX in talks to buy Boost Mobile or tap its network
Tweet
Share
E-mailGet Alerts CSTL Hot Sheet
Join SI Premium – FREE
Castle Biosciences Inc. (NASDAQ: CSTL) reported Q2 EPS of ($0.06), $0.70 better than the analyst estimate of ($0.76). Revenue for the quarter came in at $34.84 million versus the consensus estimate of $28.37 million.
For earnings history and earnings-related data on Castle Biosciences Inc. (CSTL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Morgan Stanley bearish on Coinbase, slashes target on weaker recovery
- Marriott shares rise 3% in premarket trade after raising full-year forecast
- Nvidia stock rises as chip sector recovers from Friday drop
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
